Home Opinion Can biosimilars lead us to affordability? Can biosimilars lead us to affordability?February 7, 2024Opinion By Tiffany Liesmann, PharmD, and Matthew Wittman, PharmD Prescription drug costs are undoubtedly a hot topic in our nation right now; and rightfully so. As… Login to continue reading Login Sign up for complimentary access Sign Up Now Close Previous Post With resurgence of endangered black-footed ferret, a reason to cheer in Kansas Next Post AGCO reports fourth quarter results Featured Local Savings -
Political uncertainty shakes Kansas farmland values, and prosperity hangs in the balanceSeptember 12, 2025
